UNSPSC 51313307: Promethazine teoclate

This classification denotes a phenothiazine and antipsychotic agent with the molecular formula C17H20N2S.C7H7ClN4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S5PUP23U26, chemically known as 8-chloro-3,7-dihydro-1,3-dimethyl-1h-purine-2,6-dione compd. with n,n,alpha-trimethyl-10h-phenothiazine-10-ethanamine (1:1) but more generally known as promethazine teoclate, which bears US NIH Compound Identifier 63030.

UNSPSC 51313307 Promethazine teoclate is a Commodity code that nominal state and local procurement records show minimal recent activity for. The single recent opportunity bearing this code—Seminole County, Florida's IFB 60459723LAS—solicits naloxone and safe drug deactivation systems for community health use, not promethazine teoclate, indicating a tagging misalignment between the code and the actual goods being purchased. State and local governments do use pharmaceutical commodities across health departments, county and municipal emergency services, and special districts, but the recent record under this specific code does not support a market characterization based on promethazine teoclate procurement.

Seminole County's June 2026 IFB, closed July 26, 2023 (with a noted date discrepancy in the source), represents the only recent solicitation indexed to this code. The county sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Bidders were required to submit electronically with unit costs for each line item, maintain E-Verify compliance and drug-free workplace certification, and carry workers' compensation and general liability insurance. The two-year initial term included a one-year renewal option and a three-month probationary termination window. Because this opportunity addresses opioid reversal and drug disposal rather than promethazine teoclate—an antihistamine and antiemetic—the code appears to be underutilized or mistagged for its nominal commodity, limiting utility for vendors pursuing promethazine procurement opportunities in state and local markets.